Intrauterine growth restriction--diagnosis and management

Collette Sheridan1

  • 1School of Rural Health, University of Melbourne, Australia. cms@mcmedia.com.au

Australian Family Physician
|September 27, 2005
PubMed

Insights

Accurate fetal growth assessment using customised charts helps detect intrauterine growth restriction (IUGR). Optimal management balances prematurity risks against continued intrauterine existence for the best newborn outcome.

Area of Science:

  • Obstetrics and Gynecology
  • Perinatal Medicine
  • Fetal Medicine

Background:

  • Fetal growth disorders, including intrauterine growth restriction (IUGR), contribute significantly to perinatal morbidity and mortality.
  • Long-term health implications exist for survivors of IUGR.
  • Advances in fetal growth assessment enhance obstetric care for antenatal patients and newborns.

Purpose of the Study:

  • To provide an overview of detecting fetal growth problems during pregnancy.
  • To discuss determining the causes of IUGR and its antenatal/intrapartum management.
  • To outline monitoring and management strategies based on pathophysiology.

Main Methods:

  • Utilizing customised fetal growth charts for accurate assessment.
  • Clarifying gestational age early in pregnancy.
  • Excluding infections and anomalies to differentiate fetal conditions.

Main Results:

  • Early gestational age clarification and customised charts improve fetal growth assessment accuracy.
  • Distinguishing healthy small fetuses from growth-restricted ones is crucial.
  • Optimal management focuses on delivering the newborn in the best condition.

Conclusions:

  • Accurate fetal growth assessment relies on early gestational age determination and customised charts.
  • Differentiating healthy small fetuses from those with IUGR is imperative after excluding other causes.
  • Management aims to optimize newborn condition at delivery, balancing prematurity risks with continued intrauterine life.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...